Insulet: Q4 Earnings Snapshot

In this article:

ACTON, Mass. (AP) — ACTON, Mass. (AP) — Insulet Corp. (PODD) on Thursday reported fourth-quarter earnings of $103.3 million.

On a per-share basis, the Acton, Massachusetts-based company said it had profit of $1.44. Earnings, adjusted for non-recurring gains, were $1.40 per share.

The results exceeded Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of 67 cents per share.

The maker of insulin infusion systems posted revenue of $509.8 million in the period, which also beat Street forecasts. Nine analysts surveyed by Zacks expected $460.2 million.

For the year, the company reported profit of $206.3 million, or $2.94 per share. Revenue was reported as $1.7 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PODD at https://www.zacks.com/ap/PODD

Advertisement